| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 9 |
| 1 | ASPIRIN 325 MG | 9 |
| 2 | ASPIRIN 81 MG | 9 |
| 3 | ATORVASTATIN CALCIUM | 9 |
| 4 | INCLISIRAN | 8 |
| 5 | ROSUVASTATIN | 7 |
| 6 | ATENOLOL | 6 |
| 7 | ERGOCALCIFEROL | 6 |
| 8 | DICLOFENAC | 5 |
| 9 | DICLOFENAC SODIUM | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRICLOSAN | 1 | 0.0017 |
| 1 | POTASSIUM NITRATE, SODIUM FLUORIDE | 1 | 0.0016 |
| 2 | CETYLPYRIDINIUM CHLORIDE | 1 | 0.0015 |
| 3 | STANNOUS FLUORIDE | 1 | 0.0014 |
| 4 | INCLISIRAN | 8 | 0.0009 |
| 5 | PSYLLIUM HUSK | 1 | 0.0007 |
| 6 | MARAVIROC | 1 | 0.0004 |
| 7 | GLOFITAMAB | 1 | 0.0004 |
| 8 | DARUNAVIR 600 MG | 2 | 0.0003 |
| 9 | CINNAMON | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 1 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 2 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 3 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 4 | Interleukin-17A Antagonist [EPC] | 4 | 0.0001 |
| 5 | PCSK9 Inhibitor [EPC] | 2 | 0.0001 |
| 6 | Dietary Cholesterol Absorption Inhibitor [EPC] | 6 | 0.0001 |
| 7 | Anticholinergic [EPC] | 1 | 0.0001 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 9 | Protease Inhibitor [EPC] | 2 | 0.0000 |